NeuroDerm To Issue $50M Secondary Offering

July 6, 2015 | The creator of drugs for Parkinson’s Disease, NeuroDerm reportedly issued a prospectus to raise $50 million in a second offering on NASDAQ. NeuroDerm held its original IPO in November 2014, in which it raised $45 million at a company value of $169 million, after money. Currently, NeuroDerm has a market cap of $264 million. The secondary offering is being underwritten by Jefferys and Cowen & Co. NeuroDerm was founded in 2003 and is based in Rehovot.